TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer

By sjmartinez • June 30, 2023

Bardia A, Jhaveri K, Kalinsky K, Pernas S, Tsurutani J, Xu B, Hamilton E, Im SA, Nowecki Z, Sohn J, Laurentiis M, Jañez NM, Adamo B, Lee KS, Jung KH, Rubovszky G, Tseng LM, Lu YS, Yuan Y, Maxwell MJ, Haddad V, Khan SS, Rugo HS, Pistilli B. TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer. Future Oncol. 2023 Jun 30. doi: 10.2217/fon-2023-0188. Epub ahead of print. PMID: 37387213.

Tags: antibody-drug conjugate (ADC), Cedars Sinai DoM, datopotamab deruxtecan (Dato-DXd), Hematology/Oncology, HR-positive/HER2-negative, inoperable breast cancer, metastatic breast cancer, Publications, Trophoblast cell surface antigen 2 (TROP2)

Racial and Sex Differences in Postoperative Mortality Between Patients With Versus Without Dementia

Yoshida R, Nuckols TK, Norris K, Maggard-Gibbons M, de Virgilio C, Klomhaus A, Li R, Li YJ, Tsugawa Y, Gotanda H. Racial and Sex Differences[...]

Detection of Left Ventricular Outflow Obstruction From Standard B-Mode Echocardiogram Videos Using Deep Learning

Yuan V, Ieki H, Binder C, Sahashi Y, Cheng PC, Ouyang D. Detection of Left Ventricular Outflow Obstruction From Standard B-Mode Echocardiogram Videos Using Deep[...]

Revisiting Perfusion in the Forgotten Right Ventricle: Artificial Intelligence-Enhanced Quantification on PET/CT

Shanbhag A, Miller RJH, Kavanagh P, Ramirez G, Lemley M, Kwiecinski J, Kamagate A, Slipczuk L, Travin MI, Alexanderson E, Carvajal-Juarez I, Packard RRS, Al-Mallah[...]